- Home
- RNAZ vs OPTH Comparison
RNAZ vs OPTH Comparison
Compare RNAZ & OPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNAZ | OPTH |
|---|---|---|
| Founded | 2016 | 2020 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 28.9M |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | RNAZ | OPTH |
|---|---|---|
| Price | $1.80 | $3.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 50.3K | 32.6K |
| Earning Date | 08-14-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $56.17 |
| Revenue Next Year | N/A | $82.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.52 | $3.04 |
| 52 Week High | $15.33 | $5.45 |
Technical Indicators
Market Signals| Indicator | RNAZ | OPTH |
|---|---|---|
| Relative Strength Index (RSI) | 45.70 | 26.29 |
| Support Level | $1.55 | N/A |
| Resistance Level | $2.39 | $5.21 |
| Average True Range (ATR) | 0.17 | 0.31 |
| MACD | 0.08 | -0.13 |
| Stochastic Oscillator | 68.29 | 16.96 |
Price Performance
Historical ComparisonAbout RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
About OPTH Optimi Health Corp. Common Shares
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.